Antinociceptive effects of lanthanum and cerium in nontolerant and morphine tolerant-dependent animals.
Intracerebroventricularly (i.vt.) administered lanthanum chloride was found to produce antinociceptive effects as measured by the mouse tail-flick and hot plate tests and the rat tail-flick test. These antinociceptive effects were reduced by peripheral administration of the narcotic antagonist naloxone or by i.vt. administration of calcium chloride. In addition, animals made tolerant to morphine were also tolerant to the effects of La+++. In morphine-dependent mice, the incidence of both abrupt and naloxone-precipitated withdrawal jumping was reduced by La+++ administration. In view of the known inhibitory effects of La+++ on Ca++ binding and movement, these findings suggest that alterations in Ca++ localization may be involved in the analgetic action of narcotic drugs as well as the development of narcotic tolerance and dependence.
D000700:Analgesics; D000818:Animals; D001921:Brain / Q000378:metabolism; D002118:Calcium / Q000494:pharmacology; D002563:Cerium / Q000378:metabolism / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D004347:Drug Interactions; D004361:Drug Tolerance; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009020:Morphine / Q000378:metabolism / Q000494:pharmacology; D009021:Morphine Dependence / Q000503:physiopathology*; D009270:Naloxone / Q000378:metabolism / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011930:Reaction Time / Q000187:drug effects
D000700:Analgesics; D002563:Cerium; D009270:Naloxone; D009020:Morphine; D010293:Pargyline; D000242:Cyclic AMP; D002118:Calcium